Karin studied Biomedical Sciences in Nijmegen and obtained a PhD in Maastricht with focus on pharmacology. During the years in the lab, she found out that she was passionate about communicating and “translating” science rather than performing research herself. She took on a regulatory position in 2003 and has worked in this dynamic field ever since: ten years in pharmaceutical industry (N.V. Organon) and over ten years in Zwiers Regulatory Consultancy, working on drugs early in development as well as those on the market for many years (and anything in between).  

While Regulatory Affairs is about compliance, regulations, and guidelines, it is also (or even more so) about interacting with health authorities (e.g. EMA, MEB) and researchers as well as writing and understanding research-driven documents. The position in the Radboudumc Therapy Accelerator for Rare Diseases brings together Karin’s passion for drug development and communication to the benefit of the patient.